Van Ness B - Search Results

1

Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ, Greipp PR. Fonseca R, et al. Among authors: van wier sa, van ness b. Blood. 2003 Jun 1;101(11):4569-75. doi: 10.1182/blood-2002-10-3017. Epub 2003 Feb 6. Blood. 2003. PMID: 12576322 Free article.

2

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B. Billadeau D, et al. Among authors: van ness b. Blood. 1992 Oct 1;80(7):1818-24. Blood. 1992. PMID: 1391945 Free article.

3

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B. Billadeau D, et al. Among authors: van ness b. Blood. 1991 Dec 1;78(11):3021-9. Blood. 1991. PMID: 1954387 Free article.

4

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.

Kay NE, Oken MM, Bone N, Kyle RA, Greipp P, Van Ness B, Leong T. Kay NE, et al. Among authors: van ness b. Blood. 1995 Nov 15;86(10):4000-1. Blood. 1995. PMID: 7579374 Free article. No abstract available.

5

Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells.

Kay NE, Oken MM, Kyle R, Van Ness B, Kalish L, Leong T, Greipp P. Kay NE, et al. Among authors: van ness b. Leuk Lymphoma. 1995 Jan;16(3-4):351-4. doi: 10.3109/10428199509049775. Leuk Lymphoma. 1995. PMID: 7719242 Clinical Trial.

6

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Billadeau D, Ahmann G, Greipp P, Van Ness B. Billadeau D, et al. Among authors: van ness b. J Exp Med. 1993 Sep 1;178(3):1023-31. doi: 10.1084/jem.178.3.1023. J Exp Med. 1993. PMID: 8350044 Free PMC article.

7

Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.

Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Billadeau D, et al. Among authors: van ness b. Blood. 1996 Jul 1;88(1):289-96. Blood. 1996. PMID: 8704185 Free article.

8

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.

Liu P, Leong T, Quam L, Billadeau D, Kay NE, Greipp P, Kyle RA, Oken MM, Van Ness B. Liu P, et al. Among authors: van ness b. Blood. 1996 Oct 1;88(7):2699-706. Blood. 1996. PMID: 8839865 Free article. Clinical Trial.

9

Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.

Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM. Kay NE, et al. Among authors: van ness b. Blood. 1997 Jul 1;90(1):340-5. Blood. 1997. PMID: 9207470 Free article. Clinical Trial.

10

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.

Kay NE, Leong T, Bone N, Kyle RA, Greipp PR, Van Ness B, Oken MM. Kay NE, et al. Among authors: van ness b. Br J Haematol. 1998 Mar;100(3):459-63. doi: 10.1046/j.1365-2141.1998.00609.x. Br J Haematol. 1998. PMID: 9504626 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters